Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study

FierceBiotech‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEs

Endpoints News#ADA26: Roche incretin shot works in mid-stage trial in type 1 diabetes

Clinical OMICsBlood-Based Risk Score Could Enable Earlier Lung Cancer Prevention

Clinical OMICsMicroglial State Shift May Determine Whether Alzheimer’s Disease Pathology Leads to Dementia

Endpoints NewsIn Washington, biotech's China hawks are winning the conversation

Clinical OMICsUniversal Coronavirus Vaccine Could Provide Protection Against Future Strains

Endpoints NewsIndustry seeks more clarity on commissioner's voucher program

BioWorldMoney raised by biopharma

BioWorldBiopharma money raised: Jan. 1-June 4, 2026

BioWorldBioWorld and Nasdaq stock indices

Endpoints NewsHouse committee directs FDA to speed up IND sign-off process

FierceBiotechExecutive Interviews at Fierce Biotech Week 2026